BENVIC EUROPE announces the signing of an agreement
for the acquisition of the Italian compounder MODENPLAST MEDICAL
About BENVIC EUROPE
Created in 1963, BENVIC EUROPE is the reference in the world of the compounds of the future. With a turnover of nearly 200 million euros, the international group, a historical leader in compounding, creates sustainable, innovative and eco-responsible solutions. From idea to realization among its customers, BENVIC EUROPE invests to meet the technological, functional and environmental challenges of construction, packaging, automotive and medical. With a workforce of 280 employees, BENVIC EUROPE owns four production sites in France, Italy, Spain and Poland. The Group sells its solutions in more than 60 countries. Its main markets are: France, Spain and Portugal, Italy, the United Kingdom and Ireland, Germany, Benelux and Poland. http://www.benvic.com
Benvic has acquired a majority stake in Luc & Bel, an Italian company expert in the design and manufacture of complex medical components under Class 8 cleanroom conditions, serving major international clients.
With this acquisition, Benvic further strengthens its position in the medical sector, where the Group has been active since the acquisition, in 2019, of Modenplast,
Both businesses are working hard to provide comprehensive solutions in the medic field; from polymer compounds to components.
With his expertise in manufacturing medical components L&B is capable to provide customers with also mould designs, moulding and machine adding considerable value to BENVIC’s existing expertise in polymer compounding and extrusion. With Luc and Bel and Modenplast working together, BENVIC is now a ‘one stop’ supply shop for polymer-based medical needs and know-how.